News for Avantor, Inc. (AVTR)

Discover whether Avantor, Inc. is a Buy, Sell, or Hold amidst recent stock declines. Click for more on AVTR stock and whether it is right for your portfolio.

Shares of Avantor Inc (AVTR) surged 5.47% in mid-day trading on Mar 7. The stock reached an intraday high of $17.11, before settling at $17.06, up from its

On February 27, 2025, James Bramwell, Executive Vice President of Sales, Customer Excellence at Avantor Inc, sold 4,532 shares of Avantor Inc (AVTR). Following

On December 31, 2024, T. Rowe Price Investment Management, Inc. (Trades, Portfolio) executed a significant reduction in its holdings of Avantor Inc (AVTR). The

Operator: Hello everybody and a warm welcome to Avantor's Fourth Quarter 2024 Earnings Call. My name is Emily and I'll be coordinating your call today.

Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance.

Avantor Inc.

Fourth Quarter Revenue: $1.69 billion, with 1% organic growth.Adjusted EBITDA Margin: 18.2%, highest in over a year.Adjusted Earnings Per Share (EPS): $0.27, u

Avantor Inc's robust product portfolio and global footprint provide a competitive edge in the life sciences industry.Strategic acquisitions and digital solutio

Feb 07, 2025 / 01:00PM GMTOperator Hello everybody, and a warm welcome to Avantor's fourth-quarter 2024 earnings call. My name is Emily and I coordinating your

The stock of Haemonetics Corporation (HAE) experienced a notable decline, dropping 5.06% to $59.80 per share. The trading volume reached 1.465 million shares, w

Earnings Call Insights: Avantor, Inc. (NYSE:AVTR) Q4 2024Management ViewMichael Stubblefield, CEO, highlighted Avantor's return to growth in Q4 2024 with...

Avantor, Inc. (NYSE:AVTR) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ETCompany ParticipantsAllison Hosak - SVP of Global...

Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

[url="]TriLink BioTechnologies[/url] (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, ha

In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In thi...

Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions

Growth is driven by increasing demand for semiconductors in consumer electronics, automotive applications, and emerging technologies like AI and IoT, which...

Biopreservation Market size was valued at USD 2.18 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 20.54 billion by 2031,...